If future studies provide sufficient evidence about the preventive and therapeutic effect of MI on GDM, widespread use of this drug in the general population will be possible and may lead to minimizing the use of other drugs such as insulin and also metformin, which is not approved by the United States Food and Drug Administration for using in pregnancy. Here, INS is linked to gestational diabetes.